DNM1L and prion disease: To further investigate the role of melatonin and mitochondrial dynamic proteins in prion diseases, we measured DRP1 and OPA1 expression in N2A cells treated with PrP106-126 and a DRP1 inhibitor, Mdivi-1 and in N2a cells overexpressing OPA1.